Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
A Randomized Trial of Mesenchymal Stromal Cells for Moderate to Severe Acute Respiratory Distress Syndrome from COVID-19.
Journal: American journal of respiratory and critical care medicine
Published: September 13, 2022
Mesenchymal stromal cell therapy induces high responses and survival in children with steroid refractory GVHD and poor risk biomarkers.
Journal: Bone marrow transplantation
Published: May 18, 2021
GBR 830, an anti-OX40, improves skin gene signatures and clinical scores in patients with atopic dermatitis.
Journal: The Journal of allergy and clinical immunology
Published: May 15, 2018
Showing 1-4 of 4
Last Updated: 09/26/2026